Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Mar 4, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Cara Therapeutics, Inc.
-5.83K
$0.89
-$5,192.26
-3.13%
180.52K
Feb 29
Cara Therapeutics, Inc.
-35.58K
$0.53
-$18,854.75
-16.03%
186.35K
Feb 8
Cara Therapeutics, Inc.
57.52K
$0.55
-$2,739.55
+34.98%
221.93K
Feb 1
Cara Therapeutics, Inc.
-3.80K
$1.22
-$4,631.12
-2.26%
164.41K
Nov 2
Cara Therapeutics, Inc.
-4.31K
$3.07
-$13,222.49
-2.50%
168.21K
Aug 3
Cara Therapeutics, Inc.
-3.87K
$4.40
-$17,023.60
-2.19%
172.51K
May 5
Cara Therapeutics, Inc.
-5.99K
$9.71
-$58,133.77
-3.28%
176.38K
Mar 3
Scheduled
Cara Therapeutics, Inc.
0
—
—
—
0
Mar 1
Cara Therapeutics, Inc.
-4.19K
$11.80
-$49,453.80
-2.25%
182.37K
Feb 2
Scheduled
Kempharm, Inc
0
—
—
—
0
Cara Therapeutics, Inc.
-14.47K
$11.13
-$161,051.10
-7.20%
186.56K
Nov 16
Scheduled
Cara Therapeutics, Inc.
-2.01K
$12.67
-$25,416.02
-0.99%
201.03K
Apr 4
Scheduled
Cara Therapeutics, Inc.
39K
—
—
+23.78%
203.04K
Feb 25
Cara Therapeutics, Inc.
147.94K
—
—
+919.12%
164.04K
Oct 29
Cara Therapeutics, Inc.
4.9K
$13.04
-$30,044.16
+43.71%
16.1K
Jun 3 - Jun 7
Scheduled
Cara Therapeutics, Inc.
-2.00K
$15.82
-$31,638.00
-15.15%
11.2K
Nov 19
Cara Therapeutics, Inc.
7.2K
—
—
+120.00%
13.2K
Jun 4
Cara Therapeutics, Inc.
6K
—
—
∞
6K
Jun 4
Cara Therapeutics, Inc.
0
—
—
—
0
Aug 2
Cara Therapeutics, Inc.
0
—
—
—
0

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.